Innovation Pharmaceuticals Inc (IPIX)

[Drano]

As someone just pointed out here this afternoon, the "skin products" are a different category. That is another arrow in the quiver. I don't think that something has to actually be in human trials yet to be counted; by that standard, most developmental stage biotechs would be said to have no arrows in their quiver.

CTIX has cancer arrows; infection arrows; psoriasis arrows. Arrows still to have arrowheads affixed: autism, and who knows what-all else.

And most small biotechs are lucky to have one drug, in one category, in human trials. CTIX will have 3, and more trials expected this year. I think that's getting close to a quiver-full.